Jeffrey A. Gelfand, MD

Jeffrey A. Gelfand, MD
jgelfand@partners.org

CIMIT Responsibilities:

Program Leader, Biodefense and Sepsis

Institution: MGH

Attending Physician, MGH
Clinical Professor, Harvard Medical School
Professor of Medicine, Tufts University

Background:
Dr. Gelfand is a Physician at Massachusetts General Hospital (MGH) and Clinical Professor of Medicine at Harvard Medical School, and Professor of Medicine, Tufts University. He has served as Dean for Research at Tufts University School of Medicine, Professor and Chairman of the Department of Medicine at Tufts and Physician-in-Chief at the New England Medical Center. He is now at MGH pursuing his passion for developing new therapeutics.

Dr. Gelfand has conducted laboratory and clinical research in immunology, inflammation , infection, and more recently, tumor immunology. He has developed two therapies for immune diseases that remain standard for over two decades. He has applied his background in immunology and immunotherapy to the field of vaccines for infectious diseases and cancer therapeutics. Most recently, he has developed a novel monoclonal-based, fusion- protein vaccine platform at MGH.